Caribou Biosciences Inc
NASDAQ:CRBU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Caribou Biosciences Inc
NASDAQ:CRBU
|
US |
|
Bayer AG
MIL:1BAYN
|
DE |
|
Rollins Inc
NYSE:ROL
|
US |
|
Boise Cascade Co
NYSE:BCC
|
US |
|
N
|
Nextera Energy Inc
F:FP3
|
US |
|
A
|
Adecco Group AG
SIX:ADEN
|
CH |
|
FILA Fabbrica Italiana Lapis ed Affini SpA
MIL:FILA
|
IT |
|
Entergy Corp
NYSE:ETR
|
US |
|
Ocugen Inc
NASDAQ:OCGN
|
US |
|
Chemung Financial Corp
NASDAQ:CHMG
|
US |
|
Darling Ingredients Inc
NYSE:DAR
|
US |
|
Maximus Inc
NYSE:MMS
|
US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
A
|
Andean Precious Metals Corp
XTSX:APM
|
CA |
|
PetroChina Co Ltd
OTC:PCCYF
|
CN |
|
Flowserve Corp
NYSE:FLS
|
US |
|
Lithium Americas Corp
TSX:LAC
|
CA |
|
AngloGold Ashanti Ltd
NYSE:AU
|
ZA |
|
B
|
Bank Of Princeton
NASDAQ:BPRN
|
US |
|
Xiaomi Corp
F:3CP1
|
CN |
|
CPI Card Group Inc
NASDAQ:PMTS
|
US |
Wall St Price Targets
CRBU Price Targets Summary
Caribou Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CRBU is 12.37 USD with a low forecast of 4.04 USD and a high forecast of 33.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRBU's stock price target?
Price Target
12.37
USD
According to Wall Street analysts, the average 1-year price target for
CRBU is 12.37 USD with a low forecast of 4.04 USD and a high forecast of 33.6 USD.
What is the Revenue forecast for Caribou Biosciences Inc?
Projected CAGR
135%
Over the last 5 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 8 years is 135%.